Lee Ainslie's AZN Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 1,794 shares of AstraZeneca PLC (AZN) worth $289,677, representing 0.00% of the portfolio. First purchased in 2020-Q4, this short-term holding has been held for 6 quarters.
Based on 13F filings, Lee Ainslie has maintained this position in AZN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2021, adding 20,654 shares. Largest reduction occurred in Q2 2021, reducing 15,094 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +1,794 | New Buy | 1,794 | $161.47 |
| Q4 2021 | -11,184 | Sold Out | 0 | $0.00 |
| Q3 2021 | -886 | Reduce 7.34% | 11,184 | $120.08 |
| Q2 2021 | -15,094 | Reduce 55.57% | 12,070 | $119.80 |
| Q1 2021 | +20,654 | Add 317.27% | 27,164 | $99.43 |
| Q4 2020 | +6,510 | New Buy | 6,510 | $100.00 |
Lee Ainslie's AstraZeneca PLC Investment FAQs
Lee Ainslie first purchased AstraZeneca PLC (AZN) in Q4 2020, acquiring 6,510 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held AstraZeneca PLC (AZN) for 6 quarters since Q4 2020.
Lee Ainslie's largest addition to AstraZeneca PLC (AZN) was in Q1 2021, adding 27,164 shares worth $2.7 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 1,794 shares of AstraZeneca PLC (AZN), valued at approximately $289,677.
As of the Q3 2026 filing, AstraZeneca PLC (AZN) represents approximately 0.00% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in AstraZeneca PLC (AZN) was 27,164 shares, as reported at the end of Q1 2021.